Efficacy and Safety of Dual Antiplatelet Therapy Using Cilostazol with Aspirin or Clopidogrel to Reduce the Rate of Recurrent Ischemic Stroke in Asia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Dual Antiplatelet Therapy Using Cilostazol with Aspirin or Clopidogrel to Reduce the Rate of Recurrent Ischemic Stroke in Asia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Objective: The stroke mortality rate in Asia is higher than in other regions worldwide. As an antiplatelet medication and phosphodiesterase-3 inhibitor, cilostazol lacks approval for use in ischemic stroke. We intended to analyze the efficacy and safety of cilostazol dual antiplatelet therapy (DAPT...

Full description

Saved in:
Bibliographic Details
Main Authors: Hendrawan Chandra Kusuma, Guntur Yohanes, Eugenia Isadora, Husnul Khotimah, Patricya Vira Heumasse, Ayers Gilberth Ivano Kalaij
Format: Article
Language:English
Published: Faculty of Medicine Siriraj Hospital 2025-05-01
Series:Siriraj Medical Journal
Subjects:
Aspirin
Cilostazol
Clopidogrel
Dual Antiplatelet
Ischemic Stroke
Online Access:https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/271759
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/271759

Similar Items